No sign of stopping: The rise of cell and gene therapy
Drug Discovery World
MAY 22, 2023
But are these price tags a barrier to access? Closed and automated systems are an oft-cited solution to the problems of process variability and contamination, and even under the particularly delicate therapeutic modalities of CGT, technical innovation has come along leaps and bounds over the past 10 years. million per dose.
52 
Let's personalize your content